Updated

Walmart announced it will cover Novo's Ozempic and Lilly's Mounjaro without charge for employees with Type 2 diabetes, following a change to prior authorization requirements. The move reflects growing employer willingness to subsidize high-cost weight-loss and diabetes medications as utilization surges across the workforce.